{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:44:16Z","timestamp":1787010256760,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To evaluate the effect of nalbuphine administration on urine output in critically ill children with opioid-associated urinary retention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Institutional review board approved, single center, retrospective medical chart review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Large medical-surgical PICU within a free-standing, tertiary care children\u2019s hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Patients admitted to the PICU between October 1, 2014, and February 29, 2016, who received IV nalbuphine after meeting criteria for opioid-associated oliguria (defined as urine output below 1\u2009mL\/kg\/hr and received at least one dose of opioid therapy within the preceding 12\u2009hr).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurement and Main Results:<\/jats:title>\n                    <jats:p>\n                      Seventeen patients who received 21 doses of nalbuphine were analyzed. The median age and weight of patients were 6 years (interquartile range, 3\u201311.5 yr) and 18\u2009kg (interquartile range, 12\u201335\u2009kg), respectively. Two distinct dosing strategies became evident, specifically 0.05\u2009mg\/kg (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 11 doses) and 0.1\u2009mg\/kg (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 10 doses). Urine output increased significantly from baseline (median, 0\u2009mL\/kg\/hr; interquartile range, 0\u20130.53\u2009mL\/kg\/hr) to 6 hours post nalbuphine administration (median, 1.48\u2009mL\/kg\/hr; interquartile range, 0\u20132\u2009mL\/kg\/hr;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.0002). Patients who received 0.1\u2009mg\/kg\/dose had a greater urine output response compared with those who received 0.05\u2009mg\/kg\/dose. Five patients (29%) had a catheter inserted into their bladder after administration of nalbuphine. Pain scores (grouped 6\u2009hr before and after nalbuphine administration and single pain scores documented immediately before and after nalbuphine administration) were unchanged.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Nalbuphine administration, at a dose of 0.1\u2009mg\/kg, improved urine output in a cohort of children with opioid-associated urinary retention. Pain control did not appear influenced by the provision of nalbuphine. Additional studies are needed to determine the influence of nalbuphine on urinary catheter insertion rates and catheter-associated urinary tract infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pcc.0000000000001920","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T14:37:52Z","timestamp":1554475072000},"page":"e240-e244","source":"Crossref","is-referenced-by-count":12,"title":["Nalbuphine Reduces Opioid-Associated Urinary Retention in Pediatric Patients"],"prefix":"10.1097","volume":"20","author":[{"given":"Pamela D.","family":"Reiter","sequence":"first","affiliation":[{"name":"Department of Pharmacy and Division of Pediatric Critical Care, Children\u2019s Hospital Colorado, Aurora, CO."},{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Clinical Pharmacy, Anschutz Medical Campus, Aurora, CO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Clevenger","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Critical Care, Children\u2019s Hospital Colorado and University of Colorado Denver, Anschutz Medical Campus, Aurora, CO."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230823","first-page":"186","article-title":"Patterns of off-label prescribing in the pediatric intensive care unit and prioritizing future research.","volume":"20","author":"Czaja","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/bja\/80.4.565","article-title":"Low-dose naloxone in the treatment of urinary retention during extradural fentanyl causes excessive reversal of analgesia.","volume":"80","author":"Wang","year":"1998","journal-title":"Br J Anaesth"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"F151","DOI":"10.1136\/archdischild-2011-300213","article-title":"Reversal of morphine-induced urinary retention after methylnaltrexone.","volume":"97","author":"Garten","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.clpt.6100164","article-title":"Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone.","volume":"82","author":"Rosow","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/papr.12185","article-title":"The effect of methylnaltrexone on the side effects of intrathecal morphine after orthopedic surgery under spinal anesthesia.","volume":"15","author":"Zand","year":"2015","journal-title":"Pain Pract"},{"key":"R7-20230823","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00003643-200106000-00002","article-title":"Pharmacological control of opioid-induced pruritus: A quantitative systematic review of randomized trials.","volume":"18","author":"Kjellberg","year":"2001","journal-title":"Eur J Anaesthesiol"},{"key":"R8-20230823","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1590\/S0034-70942006000100004","article-title":"[Prevention of itching after spinal sufentanil: Effects of droperidol, nalbuphine, ondansetron and the association of them.].","volume":"56","author":"Kolm","year":"2006","journal-title":"Rev Bras Anestesiol"},{"key":"R9-20230823","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0952-8180(02)00425-7","article-title":"Nalbuphine reverses urinary effects of epidural morphine: A case report.","volume":"14","author":"Malinovsky","year":"2002","journal-title":"J Clin Anesth"},{"key":"R10-20230823","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1213\/00000539-199704000-00011","article-title":"Patient-controlled epidural analgesia: Interactions between nalbuphine and hydromorphone.","volume":"84","author":"Parker","year":"1997","journal-title":"Anesth Analg"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1542\/peds.2015-1386","article-title":"Costs of venous thromboembolism, catheter-associated urinary tract infection, and pressure ulcer.","volume":"136","author":"Goudie","year":"2015","journal-title":"Pediatrics"},{"key":"R12-20230823","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1460-9592.1999.00384.x","article-title":"Efficacy and complications of morphine infusions in postoperative paediatric patients.","volume":"9","author":"Esmail","year":"1999","journal-title":"Paediatr Anaesth"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00130478-201905000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T20:12:30Z","timestamp":1692821550000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130478-201905000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000001920","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}